Economic advantage to pediatric ondansetron administration in emergency departments

Oct 12, 2010

In research published this week in PLoS Medicine, Stephen Freedman (University of Toronto) and colleagues performed a cost analysis of the emergency department administration of oral ondansetron to children with dehydration and vomiting secondary to gastroenteritis and found that this treatment could provide substantial economic, as well as clinical, benefit.

The researchers analyzed the costs of the administration of oral ondansetron in both the US and Canada, if routinely given to children with gastroenteritis-induced vomiting and dehydration in the emergency department setting and found that in the US and Canada the use of ondansetraon would provide substantial reductions in financial costs. hospitalizations and intravenous insertions.

They conclude that in countries where intravenous rehydration is often employed, the administration of oral ondansetron to children with dehydration and vomiting secondary to gastroenteritis is likely to be valuable. However, in less developed countries the emphasis for treatment of children with and vomiting should remain on oral rehydration therapy alone.

Explore further: New research demonstrates benefits of national and international device registries

More information: Freedman SB, Steiner MJ, Chan KJ (2010) Oral Ondansetron Administration in Emergency Departments to Children with Gastroenteritis: An Economic Analysis. PLoS Med 7(10): e1000350. doi:10.1371/journal.pmed.1000350

add to favorites email to friend print save as pdf

Related Stories

Rotavirus can spread beyond the intestine

Apr 17, 2007

A new study in PLoS Medicine has shown that children who have rotavirus, a very common cause of diarrhea in children, and who have antigens (protein fragments from the surface of the virus) in their blood, also have infect ...

Childhood diarrhea: Treat with zinc over 6 months of age

Jul 16, 2008

Zinc supplementation benefits children suffering from diarrhoea in developing countries, but only in infants over six months old, Cochrane Researchers have found. Their study supports World Health Organization (WHO) guidelines ...

Recommended for you

New approach to particle therapy dosimetry

4 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.